RxDoctor Payments Data

Nicholas Sich, MD

Surgical Oncology · Tacoma, WANPI 1538570338

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (54.2%), food and beverage and education — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Intuitive Surgical at 42.8% of the total.

$6,282in general payments, 2019–2025

Across 41 payments — averaging $153.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$3K
  • Medical Device Business Services, Inc.$2K
  • Johnson & Johnson$869
  • Eisai Inc.$125
  • W. L. Gore & Associates, Inc.$115
  • Boston Scientific$86
  • plus $80 from 1 others

What the payments were for

  • Travel & lodging$3,40454%
  • Food & beverage$1,87830%
  • Education$1,00016%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,282 in reported general payments places this provider in the 60th percentile of 31 surgical oncology providers in Washington.

See all surgical oncology providers in Washington

Medicare billing

Part B allowed, 2024
$149,323
Medicare patients
137
Services billed
354

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase16$13,179
Hydromorphone Hcl15$66

Paid to pharmacies, not to this prescriber.

Other surgical oncology in Tacoma

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →